The Himalayan Times
मंसिर २०७८

Moderna says booster dose of its COVID-19 vaccine appears protective vs. Omicron

Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant in laboratory testing and that the current version of the vaccine would continue to be Moderna’s "first line of defense against Omicron."

पूर्ण विवरण

सम्बन्धित सामग्री

COVID-19 booster dose to children from today

KATHMANDU, June 10: The government is administering COVID-19 booster dose to children from Friday.  According to the Ministry of Health and Population (MoHP), children aged between 12 to 17 years will be inoculated with the dose from today. All children who received their second COVID-19 vaccine three months ago are eligible for the booster dose, according to an official at the Health Ministry. Children can visit health institutions or vaccine centers nearby to receive the vaccine.

Ratopati English बैशाख २०७९

France to start administering 4th COVID-19 vaccine dose

France will start offering on Monday a fourth COVID-19 vaccination shot to people over 80 years old who have received their booster dose.

Nepalnews फाल्गुन २०७८

Moderna: Initial booster data shows good results

Nepalnews मंसिर २०७८

Sanofi, GSK say COVID-19 vaccine booster candidate give good immune response

Sanofi and GlaxoSmithKline said on Wednesday a single booster dose of their COVID-19 vaccine candidate provided strong immune responses, preliminary data from clinical trials show, a boost for the drugmakers after lagging the vaccine race.

The Himalayan Times कार्तिक २०७८

COVID-19 booster dose to be provided to fully vaccinated senior citizens

KATHMANDU, December 9: The Ministry of Health and Population (MoHP) is to administer a booster dose of COVID-19 vaccine to senior citizens, who are already vaccinated with full-dose of the vaccine.  The Ministry, on the recommendation of the National Vaccine Advisory Committee, is going to provide a booster dose to senior citizens above 60 years.   Chief of the Family Welfare Division of Department of Health Services, Dr Bibek Kumar Lal, shared that senior citizens above 60 years and already vaccinated with full-dose of vero cell, have started getting booster dose.  At a regular press briefing organised at the Ministry on Wednesday, he said that the WHO has recommended administering a booster dose to those citizens, who have already received full-dose of vero cell vaccine and are above 60 years.  The Advisory Committee has recommended a booster dose to all the people above 60 years and vaccinated with full-dose of vero cell  after three months of receiving the vaccine in Nepal. RSS

Ratopati English कार्तिक २०७८

What to Know About COVID-19 Vaccine Boosters

By Dr. Dave A. Chokshi Recently, important updates about the COVID-19 vaccine were announced—that certain people are now eligible for a “booster” dose. Since the beginning of COVID-19, our scientific understanding of the virus has constantly evolved, and many New Yorkers understandably have questions about this new development. I would like to provide the “who, […]

khasokhas.com आश्विन २०७८

Pfizer says its vaccine booster restores full protection against COVID-19

WASHINGTON, Oct. 22: Pfizer and BioNTech announced Thursday that a large-scale trial of their COVID-19 vaccine booster showed it restored full protection against the disease. In a Phase 3 randomized, controlled trial, a Pfizer-BioNTech booster dose was administered to more than 10,000 individuals 16 years of age and older, who previously received the Pfizer-BioNTech primary two-dose series. It showed a relative vaccine efficacy of 95.6 percent when compared to those who did not receive a booster. These are the first efficacy results from any randomized, controlled COVID-19 vaccine booster trial. "These results provide further evidence of the benefits of boosters as we aim to keep people well-protected against this disease," said Albert Bourla, Pfizer chairman and chief executive officer. Last month, the U.S. Food and Drug Administration authorized the booster shots for the Pfizer-BioNTech COVID-19 vaccine, allowing a single booster dose of the Pfizer-BioNTech vaccine be administered at least 6 months after completion of the primary series to individuals 65 years of age and older, and 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.

Ratopati English आश्विन २०७८

3rd COVID-19 vaccine dose boosts immunity tenfold: Israeli study

JERUSALEM, September 17: The third vaccine dose against COVID-19 increases the immune protection from infection tenfold, the Israeli Ministry of Health said on Thursday. The ministry said that a new Israeli study, published in the New England Journal of Medicine, examined the effectiveness of the third dose among those over the age of 60, who received the booster shot in August. The tenfold protection is compared to those who received only two doses at least five months ago. The study was conducted by a team of multidisciplinary researchers from the health ministry, the Weizmann Institute of Science, the Hebrew University of Jerusalem, the Technion, the Sheba Medical Center and the KI Research Institute, it said. "The data from Israel indicate high efficacy of Pfizer's third booster dose in preventing COVID-19 infection and serious illness," the ministry noted. Israel began vaccinating its population with the third vaccine dose on Aug. 1, as the Delta variant was spreading in the country and the effectiveness of the first two doses eroded. To date, nearly 3 million Israelis have received the third jab. The researchers found that 12 days after receiving the third shot, the rate of infections was more than 10 times lower among those who received the booster shot than those did not. This means that if the chance of those vaccinated with two doses to get infected with the Delta variant is about 50 percent compared to the unvaccinated, a booster dose lowers the risk to 5 percent, or raises the immune defense to 95 percent, the researchers concluded.

Ratopati English भाद्र २०७८

Booster dose of Vero Cell to be administered in Lalitpur from Friday

LALITPUR, July 7: The booster dose of China-manufactured the anti-COVID-19 vaccine, Vero Cell, is being administered in Lalitpur district on coming Friday and Saturday. The people from 60-64 age groups who have received the first dose of the vaccine (Vero Cell) are eligible to get the final shot, the District Public Health Office, Lalitpur said. Office chief Dr Khageshwor Gelal said those already receiving the first dose and waiting for the final shot are requested to visit the accessible vaccination centres on July 9 and 10 with the vaccine card and a biometric identity card. The vaccine was procured from the northern neighbour.  Meantime, the Godavari municipality has scheduled the vaccination programme at all its 14 wards on Friday. The vaccine will be available at all health posts in the wards, Kitini of Taukhel and Saraswoti Secondary School, Anandawan Hospital and the Ward-11 office as well, it is said.

Ratopati English जेष्ठ २०७८

AstraZeneca vaccine to be administered as alternative to Covishield

KATHMANDU, June 7: The government is  preparing to administer the AstraZeneca COVID-19 vaccine as an alternative to the booster dose the Covishield vaccine. The government ‘s decision comes after the Serum Institute of India, the manufacturing company of Covishield vaccine and the COVAX Facility expressed inability to supply additional quantities of Covishield vaccines to Nepal for the time being.  The Ministry of Health and Population (MOHP) is planning to administer the AstraZeneca vaccine for those waiting for the booster shot of Covishield as both vaccines are similar in nature and composition. Director of Family Welfare Division, Department of Health Services, Dr Taranath Pokhrel said that  AstraZeneca will be provided  to those receiving the first jab of Covishield as both vaccines were developed by the same company being based on the same formula and methodology and it would make no difference in giving the AstraZeneca as an alternative to the Covishield. The vaccination schedule is yet to be fixed. The booster or second dose is to be taken after 12-16 weeks of getting the first shot.   \Around 1.4 million people above 65 years of age were provided the first shot of Covishield from 7th March to  23rd March.  They are waiting for the final shot as the Serum Institute of India expressed its inability to supply one million doses of vaccines that Nepal had procured from the company for the time being in view of the increasing infections rate in India.  So far in Nepal, the number of the population receiving the first shot of COVID-19 jab stands at 2.13 million while 691,184 have received the full course. The government is administering the China –manufactured Vero Cell to the people from 60-64 age group from tomorrow, Tuesday.

Ratopati English बैशाख २०७८

Privacy

Download